Discover your next big idea at PACK EXPO Las Vegas
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries. Click to learn more.

Syntegon Enters Into Strategic Partnership with Bayer

The partnership will expand the development of new continuous manufacturing processes for oral solid dosage (OSD) forms.

Click

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The cooperation is based on the Xelum platform developed by the Syntegon subsidiary Hüttlin, which the partners intend to advance together and establish as a standard in the pharmaceutical industry. Its main advantage and a novelty in continuous pharmaceutical production is the previously unattained precise dosing of active ingredients. At the same time, fluid bed granulation provides granules with outstanding properties.

Uwe Harbauer, head of the business unit Pharma at Syntegon, confirms: "Together with Bayer, we will continue to develop our Xelum platform and tap its potential more quickly. This will enable us to align our technology even more closely with specific customer requirements. The goal is to realize a continuous line that covers all steps from powder to coated tablet."


Fill out the form below to request more information about Syntegon Enters Into Strategic Partnership with Bayer
Conveyor setup secrets from top CPG manufacturers
7 proven steps to eliminate downtime and boost packaging line efficiency. Free expert playbook reveals maintenance, sequencing, and handling strategies.
Read More
Conveyor setup secrets from top CPG manufacturers
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? Packaging World editors explore the survey responses from 118 brand owners, CPG, and FMCG Packaging World readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics